Suppr超能文献

前瞻性血液透析队列中血清促甲状腺激素水平升高与血管内皮功能障碍。

Elevated serum thyrotropin levels and endothelial dysfunction in a prospective hemodialysis cohort.

机构信息

Harold Simmons Center for Chronic Disease Research and Epidemiology, University of California Irvine School of Medicine, Orange, California, USA.

Lundquist Institute, Harbor UCLA Medical Center, Torrance, California, USA.

出版信息

Hemodial Int. 2022 Jan;26(1):57-65. doi: 10.1111/hdi.12964. Epub 2021 Jul 6.

Abstract

INTRODUCTION

Thyroid dysfunction is a highly prevalent yet under-recognized complication in hemodialysis patients. In the general population, hypothyroidism has been associated with endothelial dysfunction due to impaired vasodilator synthesis and activity. Little is known about the association of serum thyrotropin (TSH), the most sensitive and specific single biochemical metric of thyroid function, with endothelial function in hemodialysis patients.

METHODS

In a secondary analysis of 99 patients from the Anti-inflammatory and anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) trial, we examined measurements of serum TSH and endothelial function ascertained by fingertip digital thermal monitoring (DTM), a novel method used to measure micro-vascular reactivity, collected within a 90-day period. DTM was used to measure changes in fingertip temperature during and after an ischemic stimulus (blood pressure cuff occlusion) as an indicator of changes in blood flow, and two DTM indices were assessed, namely adjusted (a) Temperature Rebound (TR), defined as the maximum temperature rebound post-cuff deflation, and adjusted (b) Area Under the Temperature Curve (TMP-AUC), defined as area under the curve between the maximum and minimum temperatures. We examined the relationship between serum TSH with impaired TR (separately) and TMP-AUC (both defined as less than the median level of observed values) using multivariable logistic regression.

FINDINGS

In unadjusted and case-mix analyses, higher serum TSH levels (defined as the three highest quartiles) were associated with lower (worse) TR (ref: lowest TSH quartile): ORs (95% CI) 2.64 (1.01-6.88) and 2.85 (1.08-7.57), respectively. In unadjusted and case-mix analyses, higher TSH levels were associated with lower (worse) TMP-AUC: ORs (95% CI) 2.64 (1.01-6.88) and 2.79 (1.06-7.38), respectively.

DISCUSSION

In HD patients, higher serum TSH levels were associated with worse micro-vascular reactivity measured by DTM. Further studies are needed to determine if thyroid hormone supplementation improves endothelial function in hemodialysis patients with lower levels of thyroid function.

摘要

简介

甲状腺功能障碍是血液透析患者中一种高发但未被充分认识的并发症。在普通人群中,由于血管舒张剂合成和活性受损,甲状腺功能减退与内皮功能障碍有关。关于血清促甲状腺激素(TSH)——甲状腺功能最敏感和最特异的单一生化指标——与血液透析患者内皮功能的关系,知之甚少。

方法

在 Anti-inflammatory and anti-oxidative nutrition in hypoalbuminemic dialysis patients (AIONID) 试验的 99 名患者的二次分析中,我们检查了在 90 天内收集的指尖数字热监测(DTM)确定的血清 TSH 和内皮功能测量值,DTM 是一种用于测量微血管反应性的新方法。DTM 用于测量缺血刺激(血压袖带充气)过程中和之后指尖温度的变化,作为血流变化的指标,并评估了两个 DTM 指数,即调整后的(a)温度反弹(TR),定义为袖带放气后的最大温度反弹,以及调整后的(b)温度曲线下面积(TMP-AUC),定义为最大和最小温度之间的曲线下面积。我们使用多变量逻辑回归检查了血清 TSH 与受损的 TR(分别)和 TMP-AUC(两者均定义为低于观察值中位数水平)之间的关系。

结果

在未调整和病例组合分析中,较高的血清 TSH 水平(定义为三个最高四分位数)与较低(较差)的 TR(参考:最低 TSH 四分位数)相关:比值比(95%CI)分别为 2.64(1.01-6.88)和 2.85(1.08-7.57)。在未调整和病例组合分析中,较高的 TSH 水平与较低(较差)的 TMP-AUC 相关:比值比(95%CI)分别为 2.64(1.01-6.88)和 2.79(1.06-7.38)。

讨论

在血液透析患者中,较高的血清 TSH 水平与 DTM 测量的微血管反应性较差相关。需要进一步的研究来确定甲状腺激素补充是否可以改善甲状腺功能较低的血液透析患者的内皮功能。

相似文献

1
Elevated serum thyrotropin levels and endothelial dysfunction in a prospective hemodialysis cohort.
Hemodial Int. 2022 Jan;26(1):57-65. doi: 10.1111/hdi.12964. Epub 2021 Jul 6.
2
Serum Thyrotropin Elevation and Coronary Artery Calcification in Hemodialysis Patients.
Cardiorenal Med. 2022;12(3):106-116. doi: 10.1159/000525037. Epub 2022 May 12.
3
Thyroid Status and Mortality in a Prospective Hemodialysis Cohort.
J Clin Endocrinol Metab. 2017 May 1;102(5):1568-1577. doi: 10.1210/jc.2016-3616.
5
Thyroid Status, Quality of Life, and Mental Health in Patients on Hemodialysis.
Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1274-1283. doi: 10.2215/CJN.13211216. Epub 2017 Jul 13.
6
Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort.
J Clin Endocrinol Metab. 2016 Nov;101(11):4054-4061. doi: 10.1210/jc.2016-1691. Epub 2016 Aug 15.
7
Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.
J Clin Endocrinol Metab. 2015 Apr;100(4):1386-95. doi: 10.1210/jc.2014-4311. Epub 2015 Jan 29.
8
Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality.
Nephrol Dial Transplant. 2019 Dec 1;34(12):2095-2104. doi: 10.1093/ndt/gfy289.
9
Association of coronary artery calcium score and vascular dysfunction in long-term hemodialysis patients.
Hemodial Int. 2013 Apr;17(2):216-22. doi: 10.1111/j.1542-4758.2012.00739.x. Epub 2012 Sep 11.
10
Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients.
Am J Kidney Dis. 2014 Jun;63(6):988-96. doi: 10.1053/j.ajkd.2013.10.009. Epub 2013 Dec 4.

引用本文的文献

本文引用的文献

1
Thyroid disease in end-stage renal disease.
Curr Opin Nephrol Hypertens. 2019 Nov;28(6):621-630. doi: 10.1097/MNH.0000000000000542.
2
Thyroid Status and Death Risk in US Veterans With Chronic Kidney Disease.
Mayo Clin Proc. 2018 May;93(5):573-585. doi: 10.1016/j.mayocp.2018.01.024.
3
Thyroid Status and Mortality in a Prospective Hemodialysis Cohort.
J Clin Endocrinol Metab. 2017 May 1;102(5):1568-1577. doi: 10.1210/jc.2016-3616.
4
Associations of Macro- and Microvascular Endothelial Dysfunction With Subclinical Ventricular Dysfunction in End-Stage Renal Disease.
Hypertension. 2016 Oct;68(4):913-20. doi: 10.1161/HYPERTENSIONAHA.116.07489. Epub 2016 Aug 22.
5
The interaction between thyroid and kidney disease: an overview of the evidence.
Curr Opin Endocrinol Diabetes Obes. 2016 Oct;23(5):407-15. doi: 10.1097/MED.0000000000000275.
6
Hypothyroidism Is Associated With Coronary Endothelial Dysfunction in Women.
J Am Heart Assoc. 2015 Jul 29;4(8):e002225. doi: 10.1161/JAHA.115.002225.
7
Low-T3 Syndrome in Peritoneal Dialysis: Metabolic Adaptation, Marker of Illness, or Mortality Mediator?
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):917-9. doi: 10.2215/CJN.04310415. Epub 2015 May 15.
8
Association of thyroid functional disease with mortality in a national cohort of incident hemodialysis patients.
J Clin Endocrinol Metab. 2015 Apr;100(4):1386-95. doi: 10.1210/jc.2014-4311. Epub 2015 Jan 29.
9
The relationship between thyroid function and estimated glomerular filtration rate in patients with chronic kidney disease.
Nephrol Dial Transplant. 2015 Feb;30(2):282-7. doi: 10.1093/ndt/gfu303. Epub 2014 Sep 21.
10
Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.
Nephrol Dial Transplant. 2015 May;30(5):724-37. doi: 10.1093/ndt/gfu024. Epub 2014 Feb 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验